Northwest Biotherapeutics Presents Information On Its Prostate and Brain Cancer Initiatives
(PR Newswire)...It also presented preclinical validation findings supporting the suitability of its DCVax(TM) platform as a possible treatment for advanced brain cancer.......we were able to demonstrate both CD8+ and CD4+ T cell reactivity with only two stimulations in vitro and demonstrated tumor-specific cytolytic activity and cytokine secretion.``...- Mar 27 10:29 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010327/dctu028.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines